...
机译:KRAS和BRAF突变对肝切除后转移结直肠癌存活的影响:系统评价和荟萃分析
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
Grande Osped Metropolitano Niguarda Niguarda Canc Ctr Milan Italy;
BRAF; Colorectal cancer biomarkers; Colorectal cancer prognosis; KRAS; Liver metastases;
机译:KRAS和BRAF突变对肝切除后转移结直肠癌存活的影响:系统评价和荟萃分析
机译:KRAS和BRAF突变能否限制转移性结直肠癌患者肝切除的益处?系统评价和荟萃分析
机译:系统文献综述和描述转移结直肠癌中KRAS,NRAS和BRAF基因突变患病率的荟萃分析
机译:使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA,BRAF,PIK3CA突变
机译:葡萄糖剥夺选择结直肠癌中的KRAS和BRAF突变。
机译:根据预期的基于人群的转移性结直肠癌队列中的KRAS / BRAF突变状态和肿瘤组织可用性高BRAF突变频率和亚组的明显生存差异
机译:KRAS和BRAF突变能否限制转移性结直肠癌患者肝切除的益处?系统评价和荟萃分析